Proficio Capital Partners LLC Regeneron Pharmaceuticals, Inc. Transaction History

Proficio Capital Partners LLC

$969 Million
Q3 2024

A detailed history of Proficio Capital Partners LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Proficio Capital Partners LLC holds 236 shares of REGN stock, worth $165,811. This represents 0.03% of its overall portfolio holdings.

Number of Shares

236

Previous 302 21.85%

Holding current value

$165,811

Previous $317,000 21.77%

% of portfolio

0.03%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$1024.09 - $1201.76 $67,589 - $79,316	-66 Reduced 21.85%	236 $248,000
Q2 2024 Jul 25, 2024	SELL	$883.2 - $1071.19 $1,766 - $2,142	-2 Reduced 0.66%	302 $317,000
Q1 2024 May 02, 2024	BUY	$902.69 - $993.35 $14,443 - $15,893	16 Added 5.56%	304 $292,000
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $51,161 - $58,192	-66 Reduced 18.64%	288 $252,000
Q3 2023 Oct 18, 2023	BUY	$692.45 - $844.37 $5,539 - $6,754	8 Added 2.31%	354 $291,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $20,300 - $24,080	-29 Reduced 7.73%	346 $248,000
Q1 2023 Apr 21, 2023	SELL	$680.49 - $826.97 $209 Million - $255 Million	-307,751 Reduced 99.88%	375 $308,000
Q1 2023 Apr 19, 2023	BUY	$680.49 - $826.97 $210 Million - $255 Million	308,126 New	308,126 $253 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $189,248 - $222,100	-318 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $172,826 - $213,368	318 New	318 $201,000
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $74,928 - $87,238	-274 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $8,988 - $12,444	30 Added 12.3%	274 $86,000
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $11,534 - $13,626	31 Added 14.55%	244 $100,000
Q4 2018 Feb 08, 2019	BUY	$335.82 - $403.04 $335 - $403	1 Added 0.47%	213 $80,000
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $2,106 - $2,451	6 Added 2.91%	212 $86,000
Q2 2018 Aug 10, 2018	SELL	$284.6 - $344.99 $3,699 - $4,484	-13 Reduced 5.94%	206 $71,000
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $11,685 - $14,569	-37 Reduced 14.45%	219 $75,000
Q4 2017 Feb 09, 2018	SELL	$358.63 - $469.95 $129,106 - $169,182	-360 Reduced 58.44%	256 $96,000
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $265,730 - $310,464	616	616 $275,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.

Account

Proficio Capital Partners LLC Regeneron Pharmaceuticals, Inc. Transaction History